Circulating Tumor Cell Ctc Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00026639
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 194
Buy Now

Circulating Tumor Cell (CTC) Diagnostics Market Scope, Growth, Size and Share by 2028

Buy Now

Circulating Tumor Cell (CTC) Diagnostics Market Report Circulating Tumor Cell (CTC) Diagnostics Market Size and Share Circulating Tumor Cell (CTC) Diagnostics Market Scope and Analysis

Circulating Tumor Cell (CTC) Diagnostics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.91 Billion
Market Size by 2028 US$ 3.66 Billion
Global CAGR (2021 - 2028) 9.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • CTC Detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis
By Application
  • Clinical/Liquid Biopsy and Research
By End User
  • Hospital and Clinics
  • Research and Academic Institutes
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • STEMCELL Technologies Inc
  • QIAGEN
  • Precision Medicine Group LLC
  • Advanced Cell Diagnostics Inc BIO TECHNE CORPORATION
  • Epic Sciences
  • ScreenCell
  • Ikonisys Inc
  • IVDiagnostics

    • Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

    The global circulating tumor cell (CTC) diagnostics market is segmented on the basis of technology, application, end-user, and geography. In terms of technology, the market is segmented into CTC detection and enrichment method, CTC direct detection methods, and CTC analysis. Based on application, the global circulating tumor cell (CTC) diagnostics market is bifurcated into clinical/liquid biopsy and research. Based on end-users, the circulating tumor cell (CTC) diagnostics market is segmented into hospital and clinics, research and academic institutes, and diagnostic centers. The market, by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

    Company Profiles

    • Thermo Fisher Scientific Inc.
    • STEMCELL Technologies Inc.
    • QIAGEN
    • Precision Medicine Group, LLC.
    • Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
    • Epic Sciences
    • ScreenCell
    • Ikonisys, Inc.
    • IVDiagnostics
    • Fluxion Biosciences Inc0